3fq9
From Proteopedia
(Difference between revisions)
m (Protected "3fq9" [edit=sysop:move=sysop]) |
|||
| Line 8: | Line 8: | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3fq9]] is a 4 chain structure | + | [[3fq9]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. |
==See Also== | ==See Also== | ||
Revision as of 19:58, 20 October 2012
Contents |
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Template:ABSTRACT PUBMED 19773552
About this Structure
3fq9 is a 4 chain structure. Full crystallographic information is available from OCA.
See Also
Reference
- Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 doi:10.1074/jbc.M109.028399
Categories: Katsoyannis, P. | Phillips, N. | Wan, Z L. | Weiss, M A. | Whittaker, J. | Whittaker, L. | Xu, B. | Zhao, M. | Carbohydrate metabolism | Cleavage on pair of basic residue | Diabetes mellitus | Disease mutation | Glucose metabolism | Hormone | Insulin design | Rational | Receptor-binding | Secreted | Therapeutic implication
